SCHEMBL6507588

SCHEMBL6507588

CCCCCC[C](O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4633330 1.00 GPR84 (0.60)
SCHEMBL1768652 1.00 GPR84 (0.60)
SCHEMBL2524053 1.00 GPR84 (0.60)
SCHEMBL3422866 1.00 GPR84 (0.60)
SCHEMBL2969247 1.00 GPR84 (0.60)
SCHEMBL7461021 1.00 GPR84 (0.60)
SCHEMBL18035657 1.00 GPR84 (0.60)
SCHEMBL1542858 1.00 GPR84 (0.60)
SCHEMBL1685840 1.00 GPR84 (0.60)
SCHEMBL27497814 1.00 GPR84 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240191156-A1 TREATMENT COMPOSITIONS COMPRISING CATIONIC POLY ALPHA-1,6-GLUCAN ETHERS PROCTER & GAMBLE (US) 2024-06-13 US disclosed
US-20240141257-A1 PROCESS OF MAKING A WATER-SOLUBLE UNIT DOSE ARTICLE THE PROCTER & GAMBLE COMPANY 2024-05-02 US disclosed
EP-4353807-A1 PROCESS OF MAKING A WATER-SOLUBLE UNIT DOSE ARTICLE The Procter & Gamble Company (US) 2024-04-17 EP disclosed
US-11905495-B2 Treatment compositions comprising cationic poly alpha-1,6-glucan ethers THE PROCTER & GAMBLE COMPANY (US) 2024-02-20 US disclosed
CN-116194489-A Cationic poly alpha-1, 6-glucan ethers and compositions comprising the same 营养与生物科学美国4公司 2023-05-30 CN disclosed
EP-4168521-A1 TREATMENT COMPOSITIONS COMPRISING CATIONIC POLY ALPHA-1,6-GLUCAN ETHERS The Procter & Gamble Company (US) 2023-04-26 EP disclosed
EP-4168457-A1 CATIONIC POLY ALPHA-1,6-GLUCAN ETHERS AND COMPOSITIONS COMPRISING SAME Nutrition & Biosciences USA 4, Inc. (US) 2023-04-26 EP disclosed
CN-115836120-A Treatment compositions comprising cationic poly alpha-1, 6-glucan ethers 宝洁公司 2023-03-21 CN disclosed
US-20230045856-A1 LIQUID HAND DISHWASHING DETERGENT COMPOSITION THE PROCTER & GAMBLE COMPANY 2023-02-16 US disclosed
WO-2023013643-A1 ANTIMICROBIAL AGENT, ANTIMICROBIAL RESIN COMPOSITION AND QUATERNARY AMMONIUM SALT 東ソー株式会社 2023-02-09 WO disclosed
WO-2017098038-A1 CONTRAST AGENTS BRACCO IMAGING SPA (IT) 2017-06-15 WO disclosed
CN-102379067-B Oil resistant electronic device and method for manufacturing same OMRON TATEISI ELECTRONICS CO 2014-05-28 CN disclosed
CN-1213721-C Cosmetics prepn. compositions BASF AG (DE) 2005-08-10 CN disclosed
WO-2005035528-A2 TRIAZOLE DERIVATIVES AS ANTIBACTERIAL AGENTS DR. REDDY'S LABORATORIES LTD. (IN) 2005-04-21 WO disclosed
CN-1250648-A Cosmetics prepn. compositions BASF AG (DE) 2000-04-19 CN disclosed
EP-0331095-B1 Improving stability at moderate temperatures of motor vehicle components shaped from polyvinyl chloride resin compositions WITCO CORP (US) 1996-10-09 EP disclosed
US-4950704-A DIKETONE AS HEAT STABILIZER ARGUS CHEMICAL CORPORATION (US) 1990-08-21 US disclosed
EP-0331095-A1 Improving stability at moderate temperatures of motor vehicle components shaped from polyvinyl chloride resin compositions WITCO CORPORATION (US) 1989-09-06 EP disclosed
US-4335012-A LIQUID CRYSTALS TIMEX CORPORATION (US) 1982-06-15 US disclosed
US-4322354-A 5-Substituted-2-(4-cyanophenyl)-1,3,-dioxanes TIMEX CORPORATION (US) 1982-03-30 US disclosed